SCHEMBL6806640

SCHEMBL6806640

CC(C)(C)OC(=O)CNS(=O)(=O)c1ccc(Sc2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 6/20 0.51
MMP1 P03956 4/20 0.48
MMP2 P08253 4/20 0.48
ALDH1A1 P00352 5/20 0.47
GAA P10253 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
KDM4E B2RXH2 1/20 0.47
NPC1 O15118 1/20 0.47
HPGD P15428 1/20 0.47
RAB9A P51151 1/20 0.47
MMP12 P39900 2/20 0.46
MMP14 P50281 2/20 0.43
MEP1B Q16820 2/20 0.43
ADAMTS4 O75173 1/20 0.43
ADAMTS5 Q9UNA0 1/20 0.43
MMP3 P08254 1/20 0.43
MMP7 P09237 1/20 0.43
MMP9 P14780 1/20 0.43
MMP8 P22894 1/20 0.43
ADAM17 P78536 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28588397 0.88 ALDH1A1 (0.51) MMP13MMP1MMP2ALDH1A1GAA
SCHEMBL7669283 0.81 MEP1B (0.58) MMP13MMP1MMP2ALDH1A1GAA
SCHEMBL7669640 0.81 GHSR (0.53) ALDH1A1
SCHEMBL6802713 0.81 MMP1 (0.69) MMP13MMP1MMP2GAAKDM4E
SCHEMBL5090951 0.80 CA1 (0.57) MMP13MMP1MMP2ALDH1A1GAA
SCHEMBL19450297 0.80 MMP2 (0.56) MMP13MMP1MMP2ALDH1A1GAA
SCHEMBL6799380 0.80 ALDH1A1 (0.56) MMP13MMP1MMP2ALDH1A1GAA
SCHEMBL7667742 0.79 ALDH1A1 (0.50) MMP13MMP1MMP2ALDH1A1GAA
SCHEMBL7582747 0.79 LMNA (0.65) MMP2ALDH1A1SMN1; SMN2HPGDMMP9
SCHEMBL5892649 0.79 MMP2 (0.67) MMP13MMP1MMP2MMP14ADAMTS4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040034071-A1 Thioaryl sulfonamide hydroxamic acid compounds PHARMACIA CORPORATION 2004-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034071-A1 Thioaryl sulfonamide hydroxamic acid compounds MMP10, MMP1, MMP3 MMP13 11/4885MMP1 2/4885MMP2 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.